Post by icemandios on Mar 27, 2017 19:29:29 GMT
They harvest cells of any desired tissue type. Cells included mature cells (bad news for autoimmune response) and stem cells.
They introduce an agent that causes mature cells to self-destruct leaving stem cells. By this means, they intend to make harvesting stems cells easy, efficient, safe, and far less expensive than by other means.
Working a clinical trial, the DSMB has okayed dosing a 2nd and 3rd patient.
Read more
Friday close was 6.26, today (3/27/17) gapped open 8.77 ran to 13.50 and at 15:30, at 11.25.
They introduce an agent that causes mature cells to self-destruct leaving stem cells. By this means, they intend to make harvesting stems cells easy, efficient, safe, and far less expensive than by other means.
Working a clinical trial, the DSMB has okayed dosing a 2nd and 3rd patient.
Read more
Friday close was 6.26, today (3/27/17) gapped open 8.77 ran to 13.50 and at 15:30, at 11.25.